Clinical Trials Directory

Trials / Completed

CompletedNCT03296943

Efficacy of Inhalation of Essential Oil on the Reduction of Inhalants Craving

A Novel Approach of Substitution Therapy With Inhalation of Essential Oil for the Reduction of Inhalants Craving: A Double-blinded Randomized Controlled Trial

Status
Completed
Phase
Phase 3
Study type
Interventional
Enrollment
34 (actual)
Sponsor
Chulalongkorn University · Academic / Other
Sex
All
Age
18 Years – 65 Years
Healthy volunteers
Not accepted

Summary

Inhalants, which are neurotoxic central nervous system (CNS) suppressants, are frequently abused by young adults. Unlike other CNS depressants, including alcohol and opiates, no treatment is currently approved for inhalants dependence. In this report, a novel approach of substitution treatment for inhalants addiction was explored in a double-blinded, randomized, controlled crossover design to examine the effects of inhalation of essential oil (EO) and perfume (PF) on the reduction of cue-induced craving for inhalants in a cohort of thirty-four Thai males with inhalants dependence. The craving response was measured by the modified version of Penn Alcohol Craving Score for Inhalants (PACS-inhalants)

Conditions

Interventions

TypeNameDescription
COMBINATION_PRODUCTEssential oilTo inhale the essential oil in an air-conditioned room, the container was flipped over to soak the roll-on cap that was then rolled-on circularly at the right mid-palm of the subject at 2 centimeter in diameter for 5 cycles.
COMBINATION_PRODUCTPerfumeTo inhale the perfume in an air-conditioned room, the container was flipped over to soak the roll-on cap that was then rolled-on circularly at the right mid-palm of the subject at 2 centimeter in diameter for 5 cycles.
BEHAVIORALCue-induced inhalants cravingExposing individuals with a set of 12 pictures for one-minute (e.g., 5 second display per picture) every five minutes for three sets in total followed by another three sets of neutral/relaxing pictures of nature.

Timeline

Start date
2010-07-01
Primary completion
2010-11-30
Completion
2010-11-30
First posted
2017-09-29
Last updated
2017-09-29

Locations

1 site across 1 country: Thailand

Source: ClinicalTrials.gov record NCT03296943. Inclusion in this directory is not an endorsement.